NCT00697437View on ClinicalTrials.gov

Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Solid Tumors
Interventions
DRUG

Docetaxel

70mg q3wx 1 dose

DRUG

Ketoconazole

6 doses of oral ketoconazole 200mg bid starting 2 days before, and with 1 dose to be completed after, docetaxel infusion

Trial Locations (1)

Unknown

National University Hospital, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT00697437 - Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | Biotech Hunter | Biotech Hunter